Search Results - "RATNER, NANCY"
-
1
iGEAK: an interactive gene expression analysis kit for seamless workflow using the R/shiny platform
Published in BMC genomics (06-03-2019)“…The use of microarrays and RNA-seq technologies is ubiquitous for transcriptome analyses in modern biology. With proper analysis tools, the differential gene…”
Get full text
Journal Article -
2
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Published in The New England journal of medicine (29-12-2016)“…Plexiform neurofibroma is a complication of the NF1 mutation in neurofibromatosis that results in overactivity of the RAS pathway. Selumetinib, a…”
Get full text
Journal Article -
3
Distinct Roles for Rac1 in Sertoli Cell Function during Testicular Development and Spermatogenesis
Published in Cell reports (Cambridge) (14-04-2020)“…Sertoli cells are supporting cells of the testicular seminiferous tubules, which provide a nurturing environment for spermatogenesis. Adult Sertoli cells are…”
Get full text
Journal Article -
4
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Published in The Journal of clinical investigation (01-01-2013)“…Neurofibromatosis type 1 (NF1) patients develop benign neurofibromas and malignant peripheral nerve sheath tumors (MPNST). These incurable peripheral nerve…”
Get full text
Journal Article -
5
Merlin tumor suppressor function is regulated by PIP2-mediated dimerization
Published in PloS one (21-02-2023)“…Neurofibromatosis Type 2 is an inherited disease characterized by Schwann cell tumors of cranial and peripheral nerves. The NF2 gene encodes Merlin, a member…”
Get full text
Journal Article -
6
How does the Schwann cell lineage form tumors in NF1?
Published in Glia (01-11-2008)“…Neurofibromas are benign tumors of peripheral nerve that occur sporadically or in patients with the autosomal dominant tumor predisposition syndrome…”
Get full text
Journal Article -
7
Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis
Published in Cancer cell (12-02-2018)“…Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell (SC)-lineage-derived sarcomas. Molecular events driving SC-to-MPNST…”
Get full text
Journal Article -
8
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future
Published in JNCI : Journal of the National Cancer Institute (01-08-2017)“…Malignant peripheral nerve sheath tumor (MPNST) is an aggressive soft tissue sarcoma for which the only effective therapy is surgery. In 2016, an international…”
Get full text
Journal Article -
9
Rac1 controls Schwann cell myelination through cAMP and NF2/merlin
Published in The Journal of neuroscience (28-11-2012)“…During peripheral nervous system development, Schwann cells (SCs) surrounding single large axons differentiate into myelinating SCs. Previous studies implicate…”
Get full text
Journal Article -
10
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
Published in Nature genetics (01-07-2013)“…Eric Rahrmann and colleagues performed a transposon-based somatic mutagenesis screen for genes involved in malignant peripheral nerve sheath tumors (MPNSTs)…”
Get full text
Journal Article -
11
Neurofibromatosis type 1: modeling CNS dysfunction
Published in The Journal of neuroscience (10-10-2012)“…Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial…”
Get full text
Journal Article -
12
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis
Published in eLife (21-03-2022)“…Neurofibromatosis type 1 (NF1) is characterized by nerve tumors called neurofibromas, in which Schwann cells (SCs) show deregulated RAS signaling. NF1 is also…”
Get full text
Journal Article -
13
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
Published in American journal of medical genetics. Part A (01-03-2013)“…Schwannomatosis is the third major form of neurofibromatosis and is characterized by the development of multiple schwannomas in the absence of bilateral…”
Get full text
Journal Article Conference Proceeding -
14
Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy
Published in Oncotarget (10-10-2017)“…Successful treatment of neurofibromatosis type 1 (NF1)-associated tumors poses a significant clinical challenge. While the primary underlying genetic defect…”
Get full text
Journal Article -
15
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin
Published in PloS one (20-05-2019)“…In addition to large plexiform neurofibromas (pNF), NF1 patients are frequently disfigured by cutaneous neurofibromas (cNF) and are often afflicted with…”
Get full text
Journal Article -
16
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
Published in JCI insight (22-09-2022)“…To define alterations early in tumor formation, we studied nerve tumors in neurofibromatosis 1 (NF1), a tumor predisposition syndrome. Affected individuals…”
Get full text
Journal Article -
17
Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing Cells
Published in Cancer cell (01-02-2008)“…Neurofibromatosis type 1 ( Nf1) mutation predisposes to benign peripheral nerve (glial) tumors called neurofibromas. The point(s) in development when Nf1 loss…”
Get full text
Journal Article -
18
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors
Published in Frontiers in immunology (25-06-2024)“…Malignant peripheral nerve sheath tumors (MPNST) pose a significant therapeutic challenge due to high recurrence rates after surgical resection and a largely…”
Get full text
Journal Article -
19
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
Published in Scientific reports (23-12-2019)“…Tumors of soft tissue and bone represent a heterogeneous group of neoplasias characterized by a wide variety of genetic aberrations. Albeit knowledge on…”
Get full text
Journal Article -
20
Defective transcription elongation in a subset of cancers confers immunotherapy resistance
Published in Nature communications (23-10-2018)“…The nature and role of global transcriptional deregulations in cancers are not fully understood. We report that a large proportion of cancers have widespread…”
Get full text
Journal Article